We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWS icon
176
Zurn Elkay Water Solutions
ZWS
$8.23B
$16M 0.13%
1,098,308
-57,924
-5% -$779K
PEP icon
177
PepsiCo
PEP
$195B
$15.9M 0.13%
121,515
-98,665
-45% -$12.6M
RF icon
178
Regions Financial
RF
$26.7B
$15.9M 0.13%
1,065,430
-42,568
-4% -$629K
ITGR icon
179
Integer Holdings
ITGR
$3.41B
$15.9M 0.13%
189,517
+9,343
+5% +$700K
LOGI icon
180
Logitech
LOGI
$16B
$15.9M 0.13%
396,191
-755,605
-66% -$29.5M
STAA icon
181
STAAR Surgical
STAA
$1.13B
$15.8M 0.13%
538,154
+336,624
+167% +$9.72M
MU icon
182
Micron Technology
MU
$927B
$15.8M 0.13%
409,117
+405,988
+12,975% +$15.5M
SLB icon
183
SLB Ltd
SLB
$74.2B
$15.7M 0.13%
395,888
-4,812
-1% -$194K
SKYW icon
184
Skywest
SKYW
$4.51B
$15.7M 0.13%
258,881
+36,532
+16% +$2.16M
WTFC icon
185
Wintrust Financial
WTFC
$10.9B
$15.7M 0.13%
214,342
+851
+0.4% +$62.2K
CZR
186
DELISTED
Caesars Entertainment Corporation
CZR
$15.7M 0.13%
1,325,505
+1,120,794
+548% +$10.6M
PBF icon
187
PBF Energy
PBF
$7.22B
$15.6M 0.13%
499,260
+470,901
+1,660% +$14.1M
SEM
188
DELISTED
Select Medical
SEM
$15.6M 0.13%
1,824,153
-402,962
-18% -$3.18M
DRI icon
189
Darden Restaurants
DRI
$23.7B
$15.6M 0.13%
127,769
-24,696
-16% -$2.94M
RNG icon
190
RingCentral
RNG
$4.77B
$15.5M 0.13%
+134,901
New +$15.6M
MMM icon
191
3M
MMM
$94.1B
$15.5M 0.13%
+106,635
New +$16.4M
WHD icon
192
Cactus
WHD
$3.69B
$15.2M 0.13%
459,064
-182,593
-28% -$6.35M
AME icon
193
Ametek
AME
$55.3B
$15.2M 0.12%
166,995
+51,542
+45% +$4.42M
XNCR icon
194
Xencor
XNCR
$1.48B
$14.9M 0.12%
364,291
+338,639
+1,320% +$11.1M
VRRM icon
195
Verra Mobility
VRRM
$635M
$14.8M 0.12%
1,132,250
-167,244
-13% -$2.23M
VICI icon
196
VICI Properties
VICI
$29.8B
$14.8M 0.12%
669,787
+500,338
+295% +$11.2M
PGR icon
197
Progressive
PGR
$128B
$14.6M 0.12%
182,936
-64,621
-26% -$5M
EW icon
198
Edwards Lifesciences
EW
$48.2B
$14.3M 0.12%
231,957
+112,299
+94% +$6.79M
COR icon
199
Cencora
COR
$62.2B
$14.3M 0.12%
167,309
-50,328
-23% -$3.98M
V icon
200
Visa
V
$697B
$14.2M 0.12%
81,844
-64,082
-44% -$10.5M

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.